FDA Drug Application (202611) for MYRBETRIQ by APGDI

Back to FDA Applications sponsored by APGDI

Application Number202611
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMYRBETRIQ
Active IngredientMIRABEGRON



Back to FDA Applications sponsored by APGDI